Gamma irradiation
ANSTO operates a range of cobalt-60 gamma irradiators, providing the Australian community with a range of irradiation services for medical, health, industry, agriculture and research purposes.
Showing 1 - 20 of 36 results
ANSTO operates a range of cobalt-60 gamma irradiators, providing the Australian community with a range of irradiation services for medical, health, industry, agriculture and research purposes.
Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.
ANSTO has almost seventy years of experience in advancing an understanding of the management of spent nuclear fuel and delivering safe and reliable forms for radioactive waste.
ANSTO is a highly regulated organisation. Our governance system and processes provide critical guidance to effectively manage ANSTO’s activities. This section outlines the processes and systems that are in place to provide assurance to Government, our stakeholders and the community that we are working within our regulated and mandated requirements.
The Australian Government’s nuclear agency, ANSTO, together with NSW Police and multiple state and federal authorities, has completed an operation to repatriate radioactive waste from the UK.
Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.
Neutron Activation Analysis (NAA) is a highly sensitive method of quantitative elemental analysis. There is a wide range of potential applications for neutron irradiations.
Research and development activity explores new, boutique radioisotopes, including positron, gamma and beta/gamma emitter. The aim is to provide material for the next generation of diagnostic and therapeutic radiopharmaceuticals
CORIS360 delivers fast, accurate radiation detection and imaging, making invisible radiation visible to improve safety and decision making in radioactive environments.
Australia’s Nuclear Science and Technology Organisation (ANSTO) is well-known for facilitating incredible science and creating life-saving nuclear medicines, but for the last 40 years it’s been quietly producing a largely unsung net zero hero: Neutron Transmutation Doped (NTD) silicon.
The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been appointed Chief Executive Officer of ANSTO following a global search for the position.
ANSTO's Chief Nuclear Officer shares insights on the safe management of Australia's nuclear waste.
With a well-established portfolio of nuclear research and the operation of Australia's only nuclear reactor OPAL, ANSTO scientists conduct both fundamental and applied research on fuel for current, advanced, and future nuclear technology systems.
ANSTO is taking its innovative ANSTO Synroc® and CORIS360® technologies to the world stage at the Waste Management Symposia 2024 in Phoenix, Arizona USA this week (10 – 14 March 2024). Joining over 45 other countries and around 3,000 attendees, an Australian Government contingent comprising of ANSTO and the Australian Radioactive Waste Agency is in attendance to showcase Australia’s extensive radioactive waste management capabilities.
Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.
A new imaging technology developed at ANSTO makes it possible to image, identify and locate gamma-ray radiation in a safe and timely manner.